JPND en NIH krijgen onderscheidingen voor nieuwe transatlantische samenwerkingen
PARIJS—(BUSINESS WIRE)- Twee belangrijke entiteiten voor de financiering van onderzoek in de EU en de VS bundelen voor het eerst hun krachten om het onderzoek naar neurodegeneratieve ziekten te optimaliseren en te harmoniseren. Het EU Joint Programme on Neurodegenerative Disease Research (JPND) en het Amerikaanse National Institute on Aging (NIA), dat deel uitmaakt van de National Institutes of Health (NIH), hebben vandaag de oprichting aangekondigd van een nieuwe overkoepelende actie om de samenwerking tussen onderzoekers die op dit gebied werkzaam zijn, te koppelen en te ondersteunen.
De NIH en de JPND hebben in 2017 afzonderlijke oproepen voor voorstellen gedaan om gemeenschappelijke mechanismen en paden in neurodegeneratieve ziekten te onderzoeken.
JPND and NIH Awards to Support New Transatlantic Collaborations
PARIS–(BUSINESS WIRE)– Two major research funding entities in the EU and US are joining forces for the first time to optimise and harmonise research into neurodegenerative diseases. The EU Joint Programme on Neurodegenerative Disease Research (JPND) and the U.S. National Institute on Aging (NIA), part of the National Institutes of Health (NIH) announced today the creation of a new cross-initiative action to link and support collaborations between researchers working in the field.
NIH and JPND ran separate calls for proposals in 2017 to investigate common mechanisms and pathways in neurodegenerative diseases. With this joint action, researchers supported under the JPND call are invited to team up with researchers supported under the NIH call, and vice versa, to propose joint activities such as common workshops, data exchanges and pilot experiments. These activities will add value to the science being undertaken in ongoing projects by accelerating knowledge transfer between research groups.
“Collaboration is the key to progressing our understanding of the biological underpinnings of neurodegenerative disease,” said JPND Chair Professor Philippe Amouyel. “These awards will offer NIH and JPND researchers the opportunity to more systematically and efficiently connect and share knowledge, tools and data. They will enhance current investigations into the fundamental mechanisms of neurodegenerative diseases while also planting the seeds of future collaboration.”
“This is a crucial time of expanding global interest and support for neurodegenerative disease research,” said Dr. Eliezer Masliah, director of the NIA’s Division of Neuroscience. “In our connected age, breakthroughs in Alzheimer’s, vascular dementia, Lewy body disease, frontotemporal dementia and other neurological disorders require teamwork, and we look forward to strengthening the scientific connections between talented researchers across the EU and the US.”
Four research projects were supported under NIH’s call, “PAS17-028 Common Mechanisms and Interactions Among Neurodegenerative Diseases (R01)”. JPND’s call for “Multinational research projects for Pathway Analysis across Neurodegenerative Diseases” resulted in the support of ten research consortia, covering a range of diseases including Alzheimer’s and Parkinson’s disease.
About the EU Joint Programme on Neurodegenerative Disease Research (JPND): JPND brings together 30 countries to accelerate discovery by aligning research priorities, approaches and programmes. This has resulted in the creation of the largest global collaboration in the field and represents an innovative approach to finding causes, developing cures and identifying appropriate ways to care for people living with neurodegenerative diseases. To learn more about JPND, visit www.jpnd.eu.
About the National Institute on Aging: The NIA leads the federal government effort conducting and supporting research on aging and the health and well-being of older people. The NIA is designated as the lead NIH institute for information on Alzheimer’s disease. It provides information on age-related cognitive change and neurodegenerative disease, including participation in clinical studies, specifically on its Alzheimer’s website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180704005315/en/
Contacts
Press contacts:
JPND
Mary Hackett
JPND Communications Manager
mary.hackett@jpnd.eu